PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
30143600-10	2018	Furthermore, PN blocked 6-OHDA-induced NF-kappaB activation and IL-1beta expression.	Oxidopamine	24-30	interleukin 1 alpha	Homo sapiens	64-72	
32296327-4	2020	Results: TBA inhibited 6-OHDA-induced NLRP3 activation, as demonstrated by decreased expressions of NLRP3 and matured caspase-1 and IL-1beta, and also alleviated glial proliferation and dopaminergic neuronal degeneration.	Oxidopamine	23-29	interleukin 1 alpha	Homo sapiens	132-140	
1641068-3	1992	Injection of 6-OHDA into the PVN depleted its norepinephrine (NE) content by 85% and reduced by 80-82% the increase in plasma CS concentrations following intraperitoneal injection of recombinant human interleukin-1 alpha (IL-1), but did not affect the adrenocortical response to 20 min restraint.	Oxidopamine	13-19	interleukin 1 alpha	Homo sapiens	201-220	
18504291-8	2008	In vitro, IL-1 directly exacerbated 6-OHDA-triggered dopaminergic toxicity.	Oxidopamine	36-42	interleukin 1 alpha	Homo sapiens	10-14	
1641068-3	1992	Injection of 6-OHDA into the PVN depleted its norepinephrine (NE) content by 85% and reduced by 80-82% the increase in plasma CS concentrations following intraperitoneal injection of recombinant human interleukin-1 alpha (IL-1), but did not affect the adrenocortical response to 20 min restraint.	Oxidopamine	13-19	interleukin 1 alpha	Homo sapiens	222-226